Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2

Summary: Emerging variants of SARS-CoV-2 call for frequent changes in vaccine antigens. Nucleic acid-based vaccination strategies are superior as the coding sequences can be easily altered with little impact on downstream production. mRNA vaccines, including variant-specific boosters, are approved f...

Full description

Bibliographic Details
Main Authors: Praveen Neeli, Dafei Chai, Xu Wang, Navid Sobhani, George Udeani, Yong Li
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:iScience
Subjects:
Virology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223011975

Similar Items

Similar Items